연구전담교원 소개
문병석 연구교수
핵의학과
연구분야
방사화학, 방사성의약품 개발 및 진료 적용, 의약품후보물질 생체내 약동력학 평가
학력사항
- 1999 | 인하대학교 화학과 졸업
- 2001 | 인하대학교 이학석사
- 2009 | 인하대학교 이학박사
교육 및 연구경력
- 2020.06 - 현재 | 이화여자대학교의료원 첨단의생명연구원 분자핵의학연구소, 부소장
- 2019.03 - 현재 | 이대서울병원 핵의학과 연구부교수, 교수
- 2009.01 - 2019.02 | 분당서울대학교병원 핵의학과, Staff
- 2001.03 - 2006.02 | 한국원자력의학원 RI 및 방사성의약품개발실, 전문연구요원
수상경력
- 2026 | 대한방사성의약품 및 대한핵의학회 공동학술대회 젊은과학자상 (CA)
- 2025 | KALAS International Symposium 우수포스터상 (CA)
- 2025 | 대한방사성의약품학회 우수포스터상 (CA)
- 2023 | Society of Radiopharmaceutical Sciences International Travel Award (CA)
- 2022 | KALAS International Symposium 우수포스터상 (CA)
- 2021 | China-Japan-Korea Symposium on Radiopharmaceutical Sciences, e포스터상 (CA)
- 2019 | 대한방사성의약품학회 우수논문상 (CA)
- 2018 | 대한방사성의약품학회 우수포스터상 (CA)
- 2017 | 대한방사성의약품학회 우수논문상
- 2017 | 대한방사성의약품학회 우수포스터상
- 2013 | Society of Nuclear Medicine and Molecular Imaging, International Travel Award
- 2012 | 대한핵의학회 젊은연구자상
- 2009 | 인하대학교 대학원장상
- 2009 | Society of Radiopharmaceutical Sciences, International Travel Award
- 2007 | 한국원자력의학원 우수연구원상
- 2007 | 대한핵의학회 Fuji Film 학술상
- 2006 | 인하대학교 Inha Vision Doctoral Full Scholarship
학술관련경력
- 2026.07 - 현재 | Editorial board, Scientific Reports
- 2024.05 - 2026.04 | 대한방사성의약품학회 기획이사
- 2023.12 - 2025.11 | 대한핵의학회 평의원회 평의원
- 2022.11 - 2026.01 | 대한핵의학회 방사성의약품위원회 위원
- 2022.04 - 2024.04 | 대한방사성의약품학회 대외협력이사
- 2022.05 - 2022.12 | Guest Editor, Diagnostics
- 2021.04 - 2026.12 | Topical Advisory Panel, Diagnostics
- 2020.10 - 2022.10 | 대한핵의학회 방사성의약품위원회 위원
- 2015.11 - 2022.11 | Editorial board, J. Radiopharm. Mol. Probes
- 2003.06 - 현재 | Society of Radiopharmaceutical Sciences 정회원
- 2014.04 - 현재 | 대한방사성의약품학회 정회원
- 2005.10 - 현재 | 대한핵의학회 종신회원
- 2003.04 - 현재 | 대한화학회 종신회원
논문
- Cellular Oncology. A hydroxylated chalcone derivative disrupts the mitochondrial Thioredoxin-2–ROS axis to induce apoptosis in CD133⁺ lung cancer organoids. 2026.
- Molecular Pharmaceutics. PET imaging of phosphorylated RIPK1 reveals necroptosis activation in vivo. 2026.
- Experimental Cell Research. A novel chalcone analog inhibits cancer stemness in CD44+ and CD133+ populations via suppression of ERK signaling. 2026.
- Bulletin of the Korean Chemical Society. Feasibility of [68Ga]FAPI-46 PET for assessing fibroinflammatory remodeling in experimental chronic colitis. 2026.
- Scientific Reports. Noninvasive PET imaging of LPS-induced oxidative stress in skeletal muscle using a ROS-targeting radiotracer. 2026.
- Archives of Pharmacal Research. Unlocking drug development: the exclusive contributions of PET and SPECT imaging from molecular kinetics to therapeutic response. 2026.
- Nuclear Medicine and Molecular Imaging. Utilities of lung perfusion single-photon emission computed tomography/computed tomography (SPECT/CT) in the presence of 99mTc-macroaggregated albumin (MAA) emboli. 2025.
- Molecular Imaging and Biology. Assessment of heat stroke-induced brain injury: A preclinical study with a rat model using 18F-FDG brain PET. 2025.
- Antioxidants. Innovations in nuclear medicine imaging for reactive oxygen species: applications and radiopharmaceuticals. 2024.
- EJNMMI Research. Age and gender effects on striatal dopamine transporter density and cerebral perfusion in individuals with non-degenerative parkinsonism: a dual-phase 18F-FP-CIT PET study. 2024.
- Frontiers in Pharmacology. Pharmacokinetic evaluation of paclitaxel, albumin-binding paclitaxel, and liposomal-encapsulated albumin-binding paclitaxel in gastric subserosal administration. 2024.
- International Journal of Molecular Sciences. Application of TSPO-specific positron emission tomography radiotracer as an early indicator of acute liver failure induced by propacetamol, a prodrug of paracetamol. 2024.
- International Journal of Molecular Sciences. Radiopharmaceuticals for skeletal muscle PET imaging. 2024.
- PLOS ONE. Saengmaeksan, a traditional polyherbal formulation containing Panax ginseng, improves energy metabolism during exercise. 2024.
- PLOS ONE. Efficacy of preoperative lymphoscintigraphy in predicting surgical outcomes of lymphaticovenous anastomosis in lower extremity lymphedema: Clinical correlations in gynecological cancer-related lymphedema. 2024.
- Clinical Nuclear Medicine. Value of quantitative salivary gland SPECT/CT for the detection of saliva leakage. 2024.
- Scientific Reports. The Added Value of SPECT/CT Lymphoscintigraphy in the Initial Assessment of Secondary Extremity Lymphedema Patients. 2023.
- Bioorganic & Medicinal Chemistry. A novel chalcone derivative exerts anticancer effect by apoptotic cell death in human pancreatic cancer cell. 2023.
- Clinical and Translational Science. In vivo tissue pharmacokinetics of ERBB2-specific binding oligonucleotide based drugs by PET imaging. 2023.
- Korean Journal of Radiology. Salivary gland uptake of 18F-FP-CIT PET as a new biomarker in patients with Parkinson’s disease. 2023.
- Clinical Nuclear Medicine. Clinical impact of SPECT/CT in evaluation of abdominothoracic fistula. 2023.